ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,346.99
      -0.11%
      US Tech 100
      18,488.00
      -0.25%
      Dow Jones
      38,798.99
      -0.22%
      Brent Oil
      79.395
      0.00%
      Bitcoin
      69,423.29
      0.13%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Zura Bio Ltd (ZURA)

      7. Zura Bio Ltd (ZURA) News

      ZURA

      Zura Bio (ZURA)

      Zura Bio Ltd
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ZURA
      DateTimeSourceHeadlineSymbolCompany
      2:15PMiHub NewswireFeaturedDaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio
      06/06/20246:00AMBusiness WireZura Bio Forms Scientific Advisory Board with Prominent Specialists in Rheumatology, Dermatology, and ImmunologyNASDAQ:ZURAZura Bio Ltd
      06/03/20246:00AMBusiness WireZura Bio to Present Data Exploring the Expanded Potential of Tibulizumab (ZB-106) into Sjogren's Syndrome and Rheumatoid Arthritis at EULAR 2024NASDAQ:ZURAZura Bio Ltd
      05/29/20246:00AMBusiness WireZura Bio Announces Participation in June Investor ConferencesNASDAQ:ZURAZura Bio Ltd
      05/09/20246:00AMBusiness WireZura Bio Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:ZURAZura Bio Ltd
      04/18/20249:22AMBusiness WireZura Bio Announces Oversubscribed $112.5 Million Private PlacementNASDAQ:ZURAZura Bio Ltd
      04/08/20246:00AMBusiness WireZura Bio Announces Robert Lisicki as CEO and DirectorNASDAQ:ZURAZura Bio Ltd
      03/28/20246:00AMBusiness WireZura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive OfficerNASDAQ:ZURAZura Bio Ltd
      03/04/20246:00AMBusiness WireZura Bio Announces Participation at March ConferencesNASDAQ:ZURAZura Bio Ltd
      02/23/20244:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZURAZura Bio Ltd
      02/14/20249:02AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ZURAZura Bio Ltd
      02/02/20246:00AMBusiness WireZura Bio Announces Participation at February Investor ConferencesNASDAQ:ZURAZura Bio Ltd
      01/26/202411:32AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZURAZura Bio Ltd
      01/26/202411:30AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZURAZura Bio Ltd
      01/26/202411:27AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZURAZura Bio Ltd
      01/11/20245:25PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZURAZura Bio Ltd
      01/08/20246:03AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZURAZura Bio Ltd
      01/08/20246:00AMBusiness WireZura Bio Continues to Strengthen Leadership with Appointment of Robert Lisicki as President and Kiran Nistala as CMONASDAQ:ZURAZura Bio Ltd
      01/03/20246:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZURAZura Bio Ltd
      01/03/20246:00AMBusiness WireZura Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference and Dermatology SummitNASDAQ:ZURAZura Bio Ltd
      12/04/20236:00AMBusiness WireZura Bio Announces Two Immunology Abstracts Presented at the World Allergy Congress in BangkokNASDAQ:ZURAZura Bio Ltd
      11/17/20235:53PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ZURAZura Bio Ltd
      11/14/20236:00AMBusiness WireZura Bio Appoints Arnout Ploos van Amstel to its Board of DirectorsNASDAQ:ZURAZura Bio Ltd
      11/13/20236:30AMBusiness WireZura Bio Reports Third Quarter 2023 Financial Results and Recent Business HighlightsNASDAQ:ZURAZura Bio Ltd
      10/25/20234:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZURAZura Bio Ltd
      10/02/20239:54PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ZURAZura Bio Ltd
      10/02/20239:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZURAZura Bio Ltd
      09/15/202312:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ZURAZura Bio Ltd
      09/14/20235:01PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ZURAZura Bio Ltd
      09/14/20234:23PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZURAZura Bio Ltd
       Showing the most relevant articles for your search:NASDAQ:ZURA